Inteliquet, a leading provider of intelligent technology, insights and services for optimizing clinical trials and research, has reached a significant milestone. Working in close collaboration with cancer centers in its Clinical Consortium, Inteliquet has digitized more than 250 clinical trial protocols and proactively identified 1000 patients eligible for participation in oncology clinical trials. This directly led to 834 patients to be enrolled in a clinical trial that they otherwise would have missed.
Inteliquet also welcomes industry veteran Marie E. Lamont as Interim President and COO. Lamont was formerly President of the Patient Services Business Unit at Dolman Life Science Services, a commercial services provider to the life sciences industry.